HDI Publications by date
Search will default to “all years” unless you filter by a specific year below.
Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia.
Clements K, Dodwell D, Hilton B, Stevens-Harris I, Pinder S, Wallis MG, et al.BMJ Open 2022;12: ...
Second primary cancer risks for female and male breast cancer survivors
Isaac Allen; Tameera Rahman; Andrew Bacon; Craig Knott; Sophie Jose; Sally Vernon; Hend Hassan; Catherine ...
Amivantimab versus real-world clinical practice in Europe and the US for patients with advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations
Girard N, Wolf J, Kron A, Scheffler M, Knott CS Bosquet L et al. Amivantimab versus real-world clinical practice ...
Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England
Angela Whittle, Betina Blak, Amy Zalin-Miller, Orlaith Condon (2022) ‘Characteristics, treatment patterns and ...
The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project.
Shaaban AM, Hilton B, Clements K, Dodwell D, Sharma N, Kirwan C, et al.Br J Cancer 127, 2125–2132, 2022. ...
Change in the Use of Fractionation in Radiotherapy Used for Early Breast Cancer at the Start of the COVID-19 Pandemic
M.R. Gannon, D. Dodwell, K. Miller, K. Horgan, K. Clements, J. Medina, I. Kunkler, D.A. Cromwell,Change in the Use ...
Factors associated with the receipt of systemic treatment (tx) for metastatic urothelial carcinoma (mUC) in England
Kearney M, Knott CS, Mahmoudpour H, Verpillat P. Factors associated with the receipt of systemic treatment (tx) ...
Evolution of the treatment landscape in patients with advanced or metastatic cancers following the approval of immuno-oncology treatments
Mahmoudpour H, Knott CS, Amin A, Boutmy E, Verpillat P. Evolution of the treatment landscape in patients with ...
Previously treated recurrent or advanced endometrial cancer in England: a real-world observational analysis
Heffernan K, Sen Nikitas FS, Shukla U, Camejo HS, Knott CS. Previously treated recurrent or advanced endometrial ...
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.
Lips EH, Kumar T, Megalios A, Visser LL, Sheinman M, Fortunato A, et al.Nat Genet 54, 850–860, ...
No results found.